A detailed history of Bank Of America Corp transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Bank Of America Corp holds 499,608 shares of ORGO stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
499,608
Previous 496,540 0.62%
Holding current value
$1.77 Million
Previous $1.39 Million 2.73%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.42 - $3.24 $7,424 - $9,940
3,068 Added 0.62%
499,608 $1.43 Million
Q2 2024

Aug 14, 2024

BUY
$2.28 - $3.03 $26,546 - $35,278
11,643 Added 2.4%
496,540 $1.39 Million
Q1 2024

May 15, 2024

SELL
$2.61 - $4.49 $174,945 - $300,960
-67,029 Reduced 12.14%
484,897 $1.38 Million
Q4 2023

Feb 14, 2024

BUY
$1.97 - $4.21 $68,073 - $145,476
34,555 Added 6.68%
551,926 $2.26 Million
Q2 2023

Aug 14, 2023

BUY
$1.9 - $4.3 $858,781 - $1.94 Million
451,990 Added 691.32%
517,371 $1.72 Million
Q1 2023

May 12, 2023

SELL
$1.89 - $2.93 $39,846 - $61,773
-21,083 Reduced 24.38%
65,381 $139,000
Q4 2022

Feb 10, 2023

SELL
$2.48 - $3.43 $5,066 - $7,007
-2,043 Reduced 2.31%
86,464 $232,000
Q3 2022

Nov 14, 2022

SELL
$3.14 - $6.43 $739,975 - $1.52 Million
-235,661 Reduced 72.7%
88,507 $286,000
Q2 2022

Aug 12, 2022

BUY
$4.74 - $8.15 $280,698 - $482,634
59,219 Added 22.35%
324,168 $1.58 Million
Q1 2022

May 16, 2022

SELL
$6.47 - $9.57 $449,503 - $664,875
-69,475 Reduced 20.77%
264,949 $2.02 Million
Q4 2021

Feb 08, 2022

BUY
$9.02 - $13.5 $1.94 Million - $2.91 Million
215,447 Added 181.08%
334,424 $3.09 Million
Q3 2021

Nov 15, 2021

BUY
$13.71 - $17.18 $1.4 Million - $1.76 Million
102,364 Added 616.17%
118,977 $1.69 Million
Q2 2021

Sep 13, 2021

BUY
$14.92 - $23.23 $247,865 - $385,919
16,613 New
16,613 $276,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $465M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.